Our Science and Research

 TheraBionic Clinical Trial Research and Investigational Device Treatment focuses on:

    • Experimental Treatment Efficacy
    • Tumor shrinkage
    • Symptomatic benefit

     TheraBionic Mechanism of Action

    • Discovery of tumor-specific amplitude-modulated (AM) radiofrequency (RF) electromagnetic fields (EMF) through patient-based research
    • Identification of the intracellular pathways modulated by AM RF EMF
    • Identification of the receptor for tumor-specific frequencies
    • Discovery of tumor-specific amplitude-modulated (AM) radiofrequency (RF) electromagnetic fields (EMF) through patient-based research
    • Development of novel EMF emitting devices and methods for pulse pressure measurement led to the identification of changes in pulse pressure upon exposure to specific frequencies
    • Pulse pressure changes occur at similar frequencies for patients with the same type of cancer, irrespective of gender, age, and ethnic status
    • Frequencies eliciting the best pulse pressure responses, defined by the magnitude of increased amplitude and/or the number of heartbeats with increased amplitude, are selected as tumor-specific frequencies
    • Control individuals without a diagnosis of cancer do not exhibit changes in pulse pressure upon exposure to frequencies identified in patients with a diagnosis of cancer

    Journal of Experimental Clinical Cancer Research 2009, 28:51 and The Cancer Letter 2018, 44(27), 24-29

     

     

    What do frequencies do?

    In 2001 Pasche and Barbault began examining patients with a diagnosis of cancer with the goal of identifying cancer specific frequencies. Using noninvasive devices emitting very low and safe levels of radiofrequency electromagnetic fields, commonly named radiowaves, they discovered that patients with a diagnosis of cancer exhibited subtle but reproducible changes in their palpable pulse when exposed to certain frequencies. Next, they hypothesized that the frequencies they had discovered could be used to treat cancer and designed a study in which patients were offered experimental treatment with tumor-specific frequencies. Radiowaves modulated at the tumor-specific frequencies were delivered for three hours daily by means of a battery-operated portable device connected to a spoon-shaped antenna placed on the patient’s tongue, which results into the delivery of radiowaves throughout the body.(Barbault, Costa et al. 2009)

    Several patients enrolled in this study, published in 2009, had evidence of either tumor shrinkage or stabilization of the growth of the tumor, confirming the hypothesis that radiowaves modulated at specific tumor frequencies could block cancer growth.(Barbault, Costa et al. 2009) This hypothesis was further confirmed in a subsequent study conducted by Costa and collaborators in patients suffering from advanced hepatocellular carcinoma, which was published in 2011.(Costa, de Oliveira et al. 2011) In that study, experimental treatment with the cancer-specific radiowaves again resulted in either tumor shrinkage or tumor growth arrest in approximately half of the patients treated.(Costa, de Oliveira et al. 2011)

    In 2012, Zimmerman and collaborators working in Pasche’s laboratory demonstrated that the cancer-specific radiowaves identified in patients with a diagnosis of cancer were able to block or slow down the growth of cancer cells. These experiments were conducted with laboratory equipment replicating the same radiofrequency levels as those generated in patients receiving experimental treatment with the portable device connected to the spoon-shaped antenna. These experiments also showed that the growth of cancer cells was only blocked when tumor-specific radiowaves were used, i.e. HCC-specific radiowaves blocked the growth of HCC cells but did not affect the growth of breast cancer cells. Similarly, breast cancer-specific radiowaves blocked the growth of breast cancer cells but did not affect the growth of HCC cells. Additionally, radiowaves chosen at random did not affect the growth of any cancer cells thus confirming the well accepted concept that randomly-chosen radiowaves such as those generated by devices such as cellular phones do not affect the growth of cancer cells or normal cells.